Status:
TERMINATED
Effect of Oral Protein Supplementation on Postoperative Complications in Elderly Sarcopenic Cancerous Patients
Lead Sponsor:
Siriraj Hospital
Conditions:
Sarcopenia
Cancer
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Sarcopenia is a condition of reduced skeletal muscle associated with aging. It leads to poor outcome and increased risk of postoperative complications. Achieving protein and energy requirements is cru...
Detailed Description
Sarcopenia is a condition of reduced skeletal muscle mass associated with aging process leading to decrease muscle strength and function. International Working Group on Sarcopenia defines Sarcopenia a...
Eligibility Criteria
Inclusion
- Age of equal or more than 65 years.
- Diagnosed cancer of gastrointestinal tract, hepatopancreaticobiliary tract, urology, head and neck, ear-nose-throat or gynecological cancer.
- Scheduled for elective surgery with the duration more than 2 hours will be enrolled in this study.
Exclusion
- Unable to walk, stand up, perform hand grip test, communicate and follow commands.
- Having factors affect bioimpedance (BIA) analysis such as pacemaker, alcohol drinking or heavy exercise within 12 hours prior to analysis or take medication, herb or hormone that affect muscle mass and strength such as estrogen, testosterone, thyroxine, steroid.
- Patients diagnosed with no sarcopenia or probable sarcopenia or have a contraindication for enteral nutrition will be excluded from this study.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 28 2024
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04306562
Start Date
October 1 2019
End Date
March 28 2024
Last Update
March 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siriraj hospital
Bangkok, Thailand, 10700